Brief: Royalty Pharma Reports Third Quarter 2024 Results
06/11/2024 12:21
Nov 6 (Reuters) - Royalty Pharma PLC RPRX.O :
* ROYALTY PHARMA REPORTS THIRD QUARTER 2024 RESULTS
* ROYALTY PHARMA : EXPECTS 2024 PORTFOLIO RECEIPTS TO BE
BETWEEN
$2,750 MILLION TO $2,800 MILLION
Source text: ID:nGNX6l5grY
Further company coverage: RPRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Royalty Pharma
See all newsAnalysis: Revolution Medicines' Europe efforts signal solo launch ambitions for cancer drug
U.S. STOCKS ON THE MOVE-Best Buy, Peloton, Apple
Royalty Pharma falls after Novartis' cholesterol drug fails in study
Brief: Royalty Pharma Announces Update On Novartis’ Phase 3 Topline Results For Pelacarsen
Teva's immune disorder drug meets main goal in mid-stage trial (updated)